Robert Bruce's ABT Position Overview
Robert Bruce (via Bruce & Co., Inc.) currently holds 133.8K shares of Abbott Laboratories (ABT) worth $17.92 M, representing 5.55% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Robert Bruce has maintained a long-term strategic position in ABT, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2018, adding 40.0K shares. Largest reduction occurred in Q3 2021, reducing 77.0K shares.
Analysis based on 13F filings available since 2013 Q2
Robert Bruce's Abbott Laboratories (ABT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Abbott Laboratories (ABT) Trades by Robert Bruce
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +234,301 | Add 0.00% | 234,300 | $34.88 |
| Q3 2013 | -234,300 | Sold Out | 234,300 | $0.00 |
| Q4 2013 | +229,300 | New Buy | 229,300 | $38.33 |
| Q4 2014 | +1,615 | Add 0.70% | 230,915 | $45.02 |
| Q1 2018 | +15,800 | Add 6.84% | 246,715 | $59.92 |
| Q2 2018 | +40,000 | Add 16.21% | 286,715 | $60.99 |
| Q2 2019 | -32,115 | Reduce 11.20% | 254,600 | $84.10 |
| Q3 2021 | -77,000 | Reduce 30.24% | 177,600 | $118.12 |
| Q1 2022 | -10,000 | Reduce 5.63% | 167,600 | $118.36 |
| Q1 2023 | -757 | Reduce 0.45% | 166,843 | $101.26 |
| Q3 2023 | -6,843 | Reduce 4.10% | 160,000 | $96.85 |
| Q4 2023 | -10,000 | Reduce 6.25% | 150,000 | $110.07 |
| Q2 2024 | +2,300 | Add 1.53% | 152,300 | $103.91 |
| Q4 2024 | -4,000 | Reduce 2.63% | 148,300 | $113.11 |
| Q1 2025 | -14,500 | Reduce 9.78% | 133,800 | $132.65 |
Robert Bruce's Abbott Laboratories Investment FAQs
Robert Bruce first purchased Abbott Laboratories (ABT) in Q2 2013, acquiring 234,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce has held Abbott Laboratories (ABT) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce's largest addition to Abbott Laboratories (ABT) was in Q2 2013, adding 234,300 shares worth $8.17 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Robert Bruce's firm, Bruce & Co., Inc., owns 133,800 shares of Abbott Laboratories (ABT), valued at approximately $17.92 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Abbott Laboratories (ABT) represents approximately 5.55% of Robert Bruce's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce's peak holding in Abbott Laboratories (ABT) was 286,715 shares, as reported at the end of Q2 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.